Captopril
Back to searchMolecule Structure
Scientific Name
Captopril
Description of the Drug
Captopril is an ACE inhibitor used for the management of essential or renovascular hypertension, congestive heart failure, left ventricular dysfunction following myocardial infarction, and nephropathy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01197
http://www.drugbank.ca/drugs/DB01197
Brand Name(s)
Acepril, Capoten, Captomex, Captopril, Ecopace, Hyteneze 12.5, Hyteneze 25, Hyteneze 50, Kaplon, Lopril, Noyada, Tensobon
Company Owner(s)
Dava Pharmaceuticals Inc, Watson Laboratories Inc, Boscogen Inc, Purepac Pharmaceutical Co, Atlantide Pharmaceuticals Ag, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Prinston Pharmaceutical Inc, Cosette Pharmaceuticals Inc, Teva Pharmaceuticals Usa Inc, Ajanta Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Angiotensin-converting enzyme | SINGLE PROTEIN | INHIBITOR | CHEMBL1808 |
Clinical Trial(s)
Unichem Links
| Atlas | captopril | |
| SureChEMBL | SCHEMBL4 | |
| PharmGKB | PA448780 | |
| Human Metabolome Database | HMDB0015328 | |
| DrugBank | DB01197 | |
| PubChem: Thomson Pharma | 15195876 | 14797867 |
| PubChem | 44093 | |
| Mcule | MCULE-1716939647 | |
| LINCS | LSM-5648 | |
| Nikkaji | J3.203D | |
| PDBe | X8Z | |
| BindingDB | 21642 | |
| EPA CompTox Dashboard | DTXSID1037197 | |
| DrugCentral | 484 | |
| Brenda | 469 | 15116 |
| ChemicalBook | CB6206769 | |
| Guide to Pharmacology | 5158 | |
| rxnorm | CAPTOPRIL | |
| PubChem: Drugs of the Future | 12013747 | |
| ChEBI | 3380 | |
| ZINC | ZINC000000057001 |
